All resources are organized into categories. Click the arrow to reveal the subcategories within each category. Click any category or subcategory to view all the resources it contains.
Text search
Enter words or phrases to search for resources. Note: This searches on the resource titles and descriptions, but does not currently search the content of the resources (e.g., the text in a PDF).
Advanced Search
Tick the boxes to search any combination of category, resource format, author, publication date, and whether a resource is peer reviewed or available in French. As you check and uncheck items, the count of matching resources will update. Click the blue “SHOW RESULTS” button to view resources that match the criteria you have selected.
This DMPA-SC Advocacy Pack brief summarizes recent evidence from African countries on the costs and cost-effectiveness of DMPA-SC. Key findings include that DMPA-SC may help reduce service delivery costs by catalyzing expansion of channels closest to women and that self-injected DMPA-SC is cost-saving as compared to clinic-administered DMPA-IM when accounting for costs to women and health systems.
These DMPA-SC Advocacy Pack briefs outline existing evidence on DMPA-SC grouped into top-line messages featuring data from different countries. Several “spotlight” handouts on specific topics can be paired with the summary brief as needed. All handouts can be printed and distributed directly to decision-makers.
This DMPA-SC Advocacy Pack brief details the strong body of evidence and experience with self-injection of DMPA-SC, including how the practice can reduce access-related barriers, improve contraceptive continuation, and enhance women’s autonomy.
This DMPA-SC Advocacy Pack brief offers an overview of key policies that affect introduction and scale-up of injectable contraceptives, including DMPA-SC.
This DMPA-SC Advocacy Pack template includes a framework that supports individuals and organizations to develop a high-impact, outcome-oriented policy advocacy strategy. The template is available as a Word file in order to be customized for your context.
This DMPA-SC Advocacy Pack brief describes key evidence-building efforts, advocacy actions, and policy changes in Uganda brought about by key partners to increase access to injectable contraception, including DMPA-SC. You can draw on lessons learned from Uganda to inform your policy goals and advocacy strategy for increasing method choice and access with DMPA-SC and self-injection in your country.
This DMPA-SC Advocacy Pack brief summarizes important takeaways for advocates based on World Health Organization guidance on hormonal contraception, including DMPA injectables, and HIV for women at high risk of HIV.
One-third of contraceptive users in low- and middle-income countries access their method from a private sector source. Momentum is growing to ensure that contraceptive injectables, including DMPA-SC/self-injection, are among the range of methods offered through private channels. Speakers shared the latest evidence regarding pharmacy and drug shop provision of DMPA-SC/self-injection, updates on the release of a generic product, reflections on packaging for the private sector, and tensions between equity and financial sustainability in a changing landscape for contraceptive procurement financing. Speakers and participants discussed innovations to improve private sector channel economics and advance both equity and sustainability.
The DMPA-SC Access Collaborative has produced the brief and program design guide linked below to support countries and partners that are planning and rolling out DMPA-SC self-injection as part of an expanded range of contraceptive methods delivered through informed choice programming.
The Recommendations for Contraceptive Self-Injection brief summarizes the latest key findings, insights and recommendations the AC has accumulated through six years of technical assistance to ministries and partners engaged in self-injection program introduction and scale-up. These practices should be universally considered and implemented to increase family planning program success.
The Contraceptive Self-Injection Program Design Guide is a comprehensive tool that outlines optimal program models for DMPA-SC self-injection. It was originally developed in 2020 based on the self-injection program rollout in Uganda, the first country in sub-saharan Africa to offer contraceptive self-injection outside of a research setting. The guide was updated in 2022 to reflect subsequent learnings, evidence, and data from scale-up efforts. The program design guide:
Walks users through each step of a self-injection program, including all components related to health workers and clients.
Highlights essential evidence on self-injection program design.
Establishes areas where more research is needed.
Draws attention to key moments for program design decision-making.
Links users to additional resources and tools for program development.
Please contact FPoptions@path.org for further information or requests for assistance.
The global family planning handbook provides high-quality, up-to-date guidance for health care professionals working in low- and middle-income countries. “Chapter 4: Progestin-Only Injectables” includes information and guidance for DMPA-SC administration and self-injection.
